Ulrike Protzer

The study tracks long-term immune responses in healthcare workers after SARS-CoV-2 vaccination and infection, finding that repeated exposure boosts antibody levels while anti-N IgG wanes rapidly.

This study shows hydroxychloroquine reduces inflammation from mRNA and viral-vector therapies without affecting their therapeutic effectiveness.

This study uses DNA origami nanoshells to neutralize hepatitis B virus in cell culture by trapping the virus and enhancing antibody effectiveness through multivalent binding and physical barriers.

This study shows SARS-CoV-2 spike protein accumulates in the skull-meninges-brain axis, causing brain cell death and long-term neurological effects.

The paper reports the X-ray structure of HCV genotype 4a NS5b, an RNA-dependent RNA-polymerase, to aid in structure-based drug design.

Concurrent multi-omics of SARS-CoV-2 and SARS-CoV in A549 cells, integrated by network diffusion, maps shared and virus-specific host perturbations and nominates antiviral drug hotspots.